WT1 mRNA-electroporated autologous dendritic cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017578
A cancer vaccine containing autologous dendritic cells electroporated with full-length mRNA encoding Wilms' tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1 mRNA-electroporated autologous dendritic cell vaccine may elicit a cytotoxic T-cell (CTL) response against tumor cells expressing WT1. Wt1 is frequently overexpressed in a variety of tumor cell types and often correlates with disease progression and poor prognosis.
| Identifier | MLC-T-ONC-017578 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Wilms tumor 1 mRNA-electroporated autologous dendritic cell vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017578",
"term": "WT1 mRNA-electroporated autologous dendritic cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine containing autologous dendritic cells electroporated with full-length mRNA encoding Wilms' tumor 1 (WT1) antigen with potential immunostimulatory and antineoplastic activities. Upon administration, WT1 mRNA-electroporated autologous dendritic cell vaccine may elicit a cytotoxic T-cell (CTL) response against tumor cells expressing WT1. Wt1 is frequently overexpressed in a variety of tumor cell types and often correlates with disease progression and poor prognosis.",
"synonyms": [
"Wilms tumor 1 mRNA-electroporated autologous dendritic cell vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/wt1-mrna-electroporated-autologous-dendritic-cell-vaccine/"
}
Record 17,463 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.